Schedule of Assets and liabilities at Fair Value on Recurring Basis |
Assets and liabilities carried at fair value on a recurring basis consisted of the following (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2023 |
|
December 31, 2022 |
|
Fair Value |
|
Level 1 |
|
Level 2 |
|
Level 3 |
|
Fair Value |
|
Level 1 |
|
Level 2 |
|
Level 3 |
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assets held in rabbi trust |
$ |
9,953 |
|
|
$ |
— |
|
|
$ |
9,953 |
|
|
$ |
— |
|
|
$ |
9,553 |
|
|
$ |
— |
|
|
$ |
9,553 |
|
|
$ |
— |
|
Cash equivalents (1):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commercial paper |
$ |
39,213 |
|
|
$ |
— |
|
|
$ |
39,213 |
|
|
$ |
— |
|
|
$ |
41,324 |
|
|
$ |
— |
|
|
$ |
41,324 |
|
|
$ |
— |
|
Money market funds |
135,353 |
|
|
135,353 |
|
|
— |
|
|
— |
|
|
139,025 |
|
|
139,025 |
|
|
— |
|
|
— |
|
|
$ |
174,566 |
|
|
$ |
135,353 |
|
|
$ |
39,213 |
|
|
$ |
— |
|
|
$ |
180,349 |
|
|
$ |
139,025 |
|
|
$ |
41,324 |
|
|
$ |
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Marketable debt securities, available-for-sale: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Short-term investments: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. treasuries |
$ |
56,439 |
|
|
$ |
56,439 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
134,549 |
|
|
$ |
134,549 |
|
|
$ |
— |
|
|
$ |
— |
|
Corporate debt |
75,843 |
|
|
— |
|
|
75,843 |
|
|
— |
|
|
118,041 |
|
|
— |
|
|
118,041 |
|
|
— |
|
ABS and other |
238 |
|
|
— |
|
|
238 |
|
|
— |
|
|
844 |
|
|
— |
|
|
844 |
|
|
— |
|
|
$ |
132,520 |
|
|
$ |
56,439 |
|
|
$ |
76,081 |
|
|
$ |
— |
|
|
$ |
253,434 |
|
|
$ |
134,549 |
|
|
$ |
118,885 |
|
|
$ |
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-term investments: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. treasuries |
$ |
17,582 |
|
|
$ |
17,582 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
20,715 |
|
|
$ |
20,715 |
|
|
$ |
— |
|
|
$ |
— |
|
U.S. government sponsored entities |
530 |
|
|
— |
|
|
530 |
|
|
— |
|
|
536 |
|
|
— |
|
|
536 |
|
|
— |
|
Corporate debt |
43,573 |
|
|
— |
|
|
43,573 |
|
|
— |
|
|
41,358 |
|
|
— |
|
|
41,358 |
|
|
— |
|
ABS and other |
8,808 |
|
|
— |
|
|
8,808 |
|
|
— |
|
|
5,986 |
|
|
— |
|
|
5,986 |
|
|
— |
|
|
$ |
70,493 |
|
|
$ |
17,582 |
|
|
$ |
52,911 |
|
|
$ |
— |
|
|
$ |
68,595 |
|
|
$ |
20,715 |
|
|
$ |
47,880 |
|
|
$ |
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Contingent consideration |
$ |
7,043 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
7,043 |
|
|
$ |
7,067 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
7,067 |
|
Deferred consideration |
$ |
3,833 |
|
|
$ |
— |
|
|
$ |
3,833 |
|
|
$ |
— |
|
|
$ |
5,119 |
|
|
$ |
— |
|
|
$ |
5,119 |
|
|
$ |
— |
|
Deferred compensation liability |
$ |
7,718 |
|
|
$ |
7,718 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
6,661 |
|
|
$ |
6,661 |
|
|
$ |
— |
|
|
$ |
— |
|
|
|
|
|
|
|
(1) |
Included in cash, cash equivalents, and restricted cash on the accompanying condensed consolidated balance sheets. |
|